Table 5.

SWAL-QOL

Group	N	SWAL-QOL subscalea
		Burden			Food selection			Eat duration			Eat desire			Social effects			Symptom
		Med.	25;75b	P	Med.	25;75	P	Med.	25;75	P	Med.	25;75	P	Med.	25;75	P	Med.	25;75	P
Effect data
Group TT	14	0	−13;9	N.S.	0	0;25	N.S.	6	−15;12	N.S.	0	−8;0	N.S.	0	0;6	N.S.	10	1;19	0.004
NMES-M	17	0	0;25	N.S.	0	−6;13	N.S.	12	0;25	N.S.	0	−8;4	N.S.	0	−3;15	N.S.	4	−2;10	N.S.
NMES-S	18	6	0;37	N.S.	0	−16;0	N.S.	12	−3;37	N.S.	0	−8;17	N.S.	0	−8;16	N.S.	4	−5;11	N.S.
Total group	49	0	0;25	0.009	0	−12;6	N.S.	12	0;25	N.S.	0	−8;8	N.S.	0	0;15	N.S.	5	0;11	0,001
Follow-up minus post-treatment
Group TT	6	19	9;53	N.A.	−13	−31;6	N.A.	−12	−19;3	N.A.	0	−2;2	N.A.	0	−9;6	N.A.	10	−22;14	N.A.
NMES-M	6	0	−12;6		−19	−38;0		0	−16;25		0	0;6		0	−4;5		−4	−12; − 2
NMES-S	7	0	−25;0		0	0;12		−13	−25;0		0	−41;0		0	−25;5		0	−4;2
Total group	19	0	0;12		0	−25;0		−12	25;0		0	0;0		0	−10;5		−2	−1;7

Descriptive statistics of the effect data (post- minus pretreatment data), the number of patients per treatment group, and the level of significance of the difference between post-therapy data compared to baseline data for all groups (Wilcoxon signed-rank test)

TT traditional therapy; NMES-M neuromuscular electrical stimulation at a motor level; NMES-S neuromuscular electrical stimulation at a sensory level; Med. median. N.S. not significant; N.A. not applicable

^aThe maximum score of each scale is 100

^b25th percentile;75th percentile